Symp VId Use of Ultrasound in Preclinical Hemodynamic and Safety Assessment of Investigational Drugs

被引：0

作者：

DeFelice, Albert ^{[1
]}

机构：

[1] US FDA, Off Drug Evaluat 1, Off New Drugs, Ctr Drug Evaluat & Res, Silver Spring, MD USA

来源：

INTERNATIONAL JOURNAL OF TOXICOLOGY | 2011年 / 30卷 / 01期

关键词：

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：122 / 122

页数：1

共 37 条

[21] Evaluating the abuse potential of psychedelic drugs as part of the safety pharmacology assessment for medical use in humans
Heal, David J.
Gosden, Jane
Smith, Sharon L.
[J]. NEUROPHARMACOLOGY, 2018, 142 : 89 - 115
[22] ROLE OF REGULATORY AGENCIES AND INDUSTRY IN ASSESSMENT OF SAFETY OF DRUGS FOR USE IN MAN - SITUATION OF UNITED KINGDOM
CAHAL, DA
[J]. CANADIAN MEDICAL ASSOCIATION JOURNAL, 1968, 98 (06) : 271 - &
[23] Safety Assessment of the Use of Perflenapent Emulsion for Contrast Enhancement of Echocardiography and Diagnostic Radiology Ultrasound Studies
Quay, Steven C.
Eisenfeld, Amy J.
[J]. CLINICAL CARDIOLOGY, 1997, 20 : 19 - 26
[24] Safety of Lipiodol use for assessment of tubal patency and therapeutic tubal flushing - Fluoroscopy versus ultrasound?
Peart, Jane
Sim, Robert
[J]. JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY, 2020, 64 (04) : 522 - 524
[25] Safety assessment of the use of perflenapent emulsion for contrast enhancement of echocardiography and diagnostic radiology ultrasound studies
Quay, SC
Eisenfeld, AJ
[J]. CLINICAL CARDIOLOGY, 1997, 20 (10) : 19 - 26
[26] Utility and safety of pressure wires use in hemodynamic assessment of paradoxical low flow low gradient aortic stenosis
Fanari, Z.
Gunasekaran, P.
Shaukat, A.
Thapa, J.
Persad, P.
Hammamol, S.
Dawn, B.
Wiley, M.
Weintraub, W.
Doorey, A.
Tadros, P.
[J]. EUROPEAN HEART JOURNAL, 2017, 38 : 353 - 354
[27] The influence of systemic cryotherapy on selected hemodynamic parameters and the assessment of the safety of its use in patients with successfully treated hypertension
Wujek-Krajewska, Ewa
Cudnoch-Jedrzejewska, Agnieszka
Puchalska, Liana
Chybowska, Barbara
Janiszewski, Maciej
Klimczak, Dominika
Kuch, Marek
[J]. CRYOBIOLOGY, 2017, 78 : 22 - 26
[28] Serious adverse drug reactions related to non-investigational drugs occurring in academic clinical trials: another source of safety information for risk assessment?
Gimbert, A.
Petitpain, N.
Colin, A. L.
Becker, M.
Marty, V.
Olivier-Abbal, P.
[J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2015, 29 : 5 - 6
[29] Use of a rodent neurotoxicity screening battery in the preclinical safety assessment of recombinant-methionyl human brain-derived neurotrophic factor
LeBel, CP
Foss, JA
[J]. NEUROTOXICOLOGY, 1996, 17 (3-4) : 851 - 863
[30] ROLE OF REGULATORY AGENCIES AND INDUSTRY IN ASSESSMENT OF SAFETY OF DRUGS FOR USE IN MAN - UNITED STATES FOOD AND DRUG ADMINISTRATIONS VIEWPOINT
LEY, HL
DESMOND, FH
[J]. CANADIAN MEDICAL ASSOCIATION JOURNAL, 1968, 98 (06) : 318 - &

← 1 2 3 4 →